# EDGAR Filing Document

**Accession Number:** 0001996862
**File Stem:** 0001628280-26-037544
**Filing Date:** 2026-5
**Character Count:** 15660
**Document Hash:** ecdb2da523344534367d627d941a5a77
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-037544.hdr.sgml**: 20260522

**ACCESSION NUMBER**: 0001628280-26-037544

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260520

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260522

**DATE AS OF CHANGE**: 20260522

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bunge Global SA
- **CENTRAL INDEX KEY:** 0001996862
- **STANDARD INDUSTRIAL CLASSIFICATION:** FATS & OILS [2070]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56607
- **FILM NUMBER:** 261010828

**BUSINESS ADDRESS:**
- **STREET 1:** ROUTE DE FLORISSANT 13
- **CITY:** GENEVA
- **STATE:** V8
- **ZIP:** 1206
- **BUSINESS PHONE:** 41 22 592 91 00

**MAIL ADDRESS:**
- **STREET 1:** ROUTE DE FLORISSANT 13
- **CITY:** GENEVA
- **STATE:** V8
- **ZIP:** 1206

?xml version='1.0' encoding='ASCII'? bg-20260520

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**___________________________________**

**FORM 8-K**

**___________________________________**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**May 20, 2026**

Date of Report (date of earliest event reported)

**___________________________________**

**BUNGE GLOBAL SA**

(Exact name of registrant as specified in its charter)

**___________________________________**

**Switzerland**<br>(State of Incorporation)<br>

---

| | |
|:---|:---|
| **000-56607**<br>(Commission File Number) | **98-1743397**<br>(IRS Employer Identification Number) |
| **Route de Florissant 13,**<br>**1206 Geneva, Switzerland** | **N.A** |
| (Address of registered office and principal executive office) | (Zip Code) |
| **1391 Timberlake Manor Parkway**<br>**Chesterfield, MO** | **63017** |
| (Address of corporate headquarters) | (Zip Code) |
| **(314) 292-2000** | **(314) 292-2000** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
| **N/A** | **N/A** |
| (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

**☐** Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

**☐** Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

**☐** Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

**☐** Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| **Registered Shares, $0.01 par value per share** | **BG** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

 **5.07 - Submission of Matters to a Vote of Security Holders**

At the 2026 Annual General Meeting of Shareholders of Bunge Global SA (the "Company") held on May 20, 2026 (the "AGM"), the Company's shareholders voted on the proposals set forth below, each of which is described in the Company's proxy statement for the 2026 AGM:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The shareholders approved the Swiss statutory consolidated financial statements and Swiss standalone statutory financial statements of the Company for the year ended December 31, 2025. The tabulation of votes on this matter was as follows:

---

| | | |
|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> |
| 171,395,342 | 307,890 | 196,085 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders approved the appropriation of the available earnings for fiscal year 2025. The tabulation of votes on this matter was as follows:

---

| | | |
|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> |
| 171,799,489 | 42,298 | 57,530 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders approved a cash dividend in the aggregate amount of U.S. $2.88 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows:

---

| | | |
|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> |
| 171,819,584 | 34,587 | 45,146 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders approved the discharge of the members of the Board and the Executive Management Team from liability for activities during fiscal year 2025. The tabulation of votes on this matter was as follows:

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| 164,200,220 | 1,446,173 | 1,057,912 | 5,195,012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders elected the following 12 individuals listed below as directors, each for a term extending until completion of the 2027 annual general meeting. The tabulation of votes with respect to the reelection of the directors below was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | <u>Nominee</u> | <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;5a. | Eliane Aleixo Lustosa de Andrade | 165621710  | 1006220 | 76375 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5b. | Carol Browner | 158368349  | 8258978 | 76978 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5c. | Gregory Heckman | 166217927  | 426143 | 60235 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5d. | Adrian Isman | 165256608  | 1380901 | 66796 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5e. | Anne Jensen | 166537587  | 93469 | 73249 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5f. | Linda Jojo | 165440013  | 1187070 | 77222 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5g. | Christopher Mahoney | 166451243  | 174480 | 78582 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5h. | Monica McGurk | 166239086  | 400804 | 64415 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5i. | Kenneth Simril | 161103809  | 5526866 | 73630 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5j. | Markus Walt | 148564760  | 18065303 | 74242 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5k. | Henry "Jay" Winship | 165282174  | 1346177 | 75954 | 5195012 |
| &nbsp;&nbsp;&nbsp;&nbsp;5l. | Mark Zenuk | 154156154  | 11627766 | 920385 | 5195012 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders reelected Mark Zenuk as the Chair of the Board. The tabulation of votes with respect to the reelection of the Chair of the Board was as follows:

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| 152,835,402  | 12,866,318 | 1,002,585 | 5,195,012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders reelected each of the four members of the Human Resources and Compensation Committee. The tabulation of votes with respect to the reelection of the four members of the Human Resources and Compensation Committee was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | <u>Nominee</u> | <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| &nbsp;&nbsp;&nbsp;7a. | Monica McGurk | 166228208 | 411750 | 64347 | 5195012 |
| &nbsp;&nbsp;&nbsp;7b. | Kenneth Simril | 165502943 | 1136156 | 65206 | 5195012 |
| &nbsp;&nbsp;&nbsp;7c. | Markus Walt | 148457149 | 18178573 | 68583 | 5195012 |
| &nbsp;&nbsp;&nbsp;7d. | Henry "Jay" Winship | 165809633 | 826445 | 68227 | 5195012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders passed an advisory vote to approve the Named Executive Officers compensation under U.S. securities law requirements. The tabulation of votes with respect to this matter was as follows:

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| 163,283,955 | 3,231,095 | 189,255 | 5,195,012 |

---

9a.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders approved the maximum aggregate compensation of the Board for the period between the 2026 annual general meeting and the 2027 annual general meeting. The tabulation of votes with respect to this matter was as follows:

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| 166,160,353 | 286,031 | 257,921 | 5,195,012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;9b.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders approved the maximum aggregate compensation of the Executive Management Team for the fiscal year 2027. The tabulation of votes with respect to this matter was as follows:

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| 164,995,366  | 1,448,887 | 260,052 | 5,195,012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;9c.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders passed an advisory vote on the Swiss Compensation Report. The tabulation of votes with respect to this matter was as follows:

---

| | | | |
|:---|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> | <u>Broker Non-Votes</u> |
| 163,961,052  | 2,529,806 | 213,447 | 5,195,012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders passed an advisory vote on the Swiss Statutory Non-Financial Matter Report. The tabulation of votes with respect to this matter was as follows:

---

| | | |
|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> |
| 169,722,306 | 1,930,435 | 246,576 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders elected the Swiss Statutory Independent Voting Representative. The tabulation of votes with respect to this matter was as follows:

---

| | | |
|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> |
| 171,728,532 | 55,202 | 115,583 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;&nbsp;&nbsp;&nbsp;The shareholders approved the appointment of the independent auditor for U.S. securities law requirements and reelected the statutory auditor for Swiss law requirements. The tabulation of votes with respect to this matter was as follows:

---

| | | |
|:---|:---|:---|
| <u>Votes For</u> | <u>Votes Against</u> | <u>Abstentions</u> |
| 160,308,430 | 11,502,297 | 88,590 |

---

**Item 9.01 - Financial Statements and Exhibits**

(d): &nbsp;&nbsp;&nbsp;&nbsp;Exhibits.

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| <u>[99.1](a991-bungedeclaresquarterl.htm)</u> | Press Release, dated May 20, 2026 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 22, 2026

---

| | |
|:---|:---|
| **BUNGE GLOBAL SA** | **BUNGE GLOBAL SA** |
| By: | /s/ Lisa Ware-Alexander |
| Name: | Lisa Ware-Alexander |
| Title: | Secretary |

---

## Exhibit 99.1

![image_1.jpg](image_1.jpg)

![image_0.jpg](image_0.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Media Contact: Bunge News Bureau636-359-0797<u>news@bunge.com</u> <br> Investor Contact: <br> Mark HadenBunge <u>mark.haden@bunge.com</u>

**Bunge Announces Approval of Increased Quarterly Dividends** 

**at 2026 Annual General Meeting** 

**St. Louis, MO – May 20, 2026** – Shareholders of Bunge Global SA (NYSE: BG) approved a cash dividend in the amount of $2.88 per share, payable in four equal installments of $0.72, at the Company's 2026 Annual General Meeting held in Geneva, Switzerland, today ("AGM"). The quarterly dividends, which represent an increase of $0.02 per share from last year, will be paid as indicated below:

---

| | | | |
|:---|:---|:---|:---|
| **<u>Bunge Quarter, Fiscal Year</u>** | **<u>Payment Date</u>** | **<u>Record Date</u>** | **<u>Amount</u>** |
| 2<sup>nd</sup> Quarter, Fiscal Year 2026 | June 1, 2026 | May 22, 2026 | $0.72 |
| 3<sup>rd</sup> Quarter, Fiscal Year 2026 | September 1, 2026 | August 18, 2026 | $0.72 |
| 4<sup>th</sup> Quarter, Fiscal Year 2026 | December 1, 2026 | November 17, 2026 | $0.72 |
| 1<sup>st</sup> Quarter, Fiscal Year 2027 | March 2, 2027 | February 16, 2027 | $0.72 |

---

**About Bunge**

At Bunge our purpose is to connect farmers to consumers to deliver essential food, feed, and fuel to the world. As a premier agribusiness solutions provider, our dedicated employees partner with farmers across the globe to move agricultural commodities from where they're grown to where they're needed—in faster, smarter, and more efficient ways. We are a world leader in grain origination, storage, distribution, oilseed processing and refining, offering a broad portfolio of plant-based oils, fats, and proteins. We work alongside our customers at both ends of the value chain to deliver quality products and develop tailored, innovative solutions that address evolving consumer needs. With 200+ years of experience and presence in over 50 countries, we are committed to strengthening global food security, advancing sustainability, and helping communities prosper where we operate. Bunge has its registered office in Geneva, Switzerland, and its corporate headquarters in St. Louis, Missouri. Learn more at Bunge.com.

**Website Information**<br>

We routinely post important information for investors on our website, www.bunge.com, in the "Investor Center" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

###

<br>